4.6 Review

Implantable cardiac devices in sleep apnoea diagnosis: A systematic review and meta-analysis

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 348, Issue -, Pages 76-82

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2021.12.014

Keywords

Sleep apnoea syndrome; Diagnosis; Pacemaker; Implantable cardiac defibrillator; Polysomnography

Ask authors/readers for more resources

This study evaluated the performance of implantable cardiac devices for sleep apnoea diagnosis and found that they have a clinically relevant respiratory disturbance index, which may improve access to sleep apnoea diagnosis in at-risk cardiovascular populations.
Background: A particularly high burden of sleep apnoea is reported in patients treated with cardiac implants such as pacemakers and defibrillators. Sleep apnoea diagnosis remains a complex procedure mainly based on sleep and respiratory indices captured by polysomnography (PSG) or respiratory polygraphy (PG). Aim: We aimed to evaluate the performance of implantable cardiac devices for sleep apnoea diagnosis compared to reference methods. Method: Systematic structured literature searches were performed in PubMed, Embase and. Cochrane Library was performed to identify relevant studies. Quantitative characteristics of the studies were summarized and a qualitative synthesis was performed by a randomized bivariate meta-analysis and completed by pre-specified sensitivity analyses for different implant types and brands. Results: 16 studies involving 999 patients met inclusion criteria and were included in the meta-analysis. The majority of patients were men, of mean age of 64 +/- 4.6 years. Sensitivity of cardiac implants for sleep apnoea diagnosis ranged from 60 to 100%, specificity from 50 to 100% with a prevalence of sleep apnoea varying from 22 to 91%. For an apnoea-hypopnoea index threshold >= 30 events/h during polysomnography (corresponding to severe sleep apnoea), the overall performance of the implants was relevant with a sensitivity of 78% and a specificity of 79%. Subgroup analyses on implant type and brand provided no additional information owing to the small number of studies. Conclusion: The respiratory disturbance index provided by cardiac implants is clinically relevant and might improve access to sleep apnoea diagnosis in at-risk cardiovascular populations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available